These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33779725)

  • 1. Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy.
    Mancio J; Pashakhanloo F; El-Rewaidy H; Jang J; Joshi G; Csecs I; Ngo L; Rowin E; Manning W; Maron M; Nezafat R
    Eur Heart J Cardiovasc Imaging; 2022 Mar; 23(4):532-542. PubMed ID: 33779725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Texture signatures of native myocardial T
    Neisius U; El-Rewaidy H; Kucukseymen S; Tsao CW; Mancio J; Nakamori S; Manning WJ; Nezafat R
    J Magn Reson Imaging; 2020 Sep; 52(3):906-919. PubMed ID: 31971296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of fibrosis in hypertrophic cardiomyopathy: a radiomic study on cardiac magnetic resonance cine imaging.
    Pu C; Hu X; Lv S; Wu Y; Yu F; Zhu W; Zhang L; Fei J; He C; Ling X; Wang F; Hu H
    Eur Radiol; 2023 Apr; 33(4):2301-2311. PubMed ID: 36334102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A radiomic approach to predict myocardial fibrosis on coronary CT angiography in hypertrophic cardiomyopathy.
    Qin L; Chen C; Gu S; Zhou M; Xu Z; Ge Y; Yan F; Yang W
    Int J Cardiol; 2021 Aug; 337():113-118. PubMed ID: 33961944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic machine learning based on native T1 mapping can identify myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Peng WL; Zhang TJ; Shi K; Li HX; Li Y; He S; Li C; Xia D; Xia CC; Li ZL
    Eur Radiol; 2022 Feb; 32(2):1044-1053. PubMed ID: 34477909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy-Preliminary results.
    Baeßler B; Mannil M; Maintz D; Alkadhi H; Manka R
    Eur J Radiol; 2018 May; 102():61-67. PubMed ID: 29685546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Segmental longitudinal strain as the most accurate predictor of the patchy pattern late gadolinium enhancement in hypertrophic cardiomyopathy.
    Wabich E; Dorniak K; Zienciuk-Krajka A; Nowak R; Raczak G; Daniłowicz-Szymanowicz L
    J Cardiol; 2021 May; 77(5):475-481. PubMed ID: 33246844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young.
    Österberg AW; Östman-Smith I; Jablonowski R; Carlsson M; Green H; Gunnarsson C; Liuba P; Fernlund E
    Pediatr Cardiol; 2021 Mar; 42(3):492-500. PubMed ID: 33515326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular late potentials and myocardial fibrosis in hypertrophic cardiomyopathy.
    Matsuki A; Kawasaki T; Kawamata H; Sakai C; Harimoto K; Kamitani T; Yamano M; Matoba S
    J Electrocardiol; 2020; 58():87-91. PubMed ID: 31790854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
    JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy.
    Fahmy AS; Rowin EJ; Arafati A; Al-Otaibi T; Maron MS; Nezafat R
    J Cardiovasc Magn Reson; 2022 Jun; 24(1):40. PubMed ID: 35761339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.
    Aquaro GD; Positano V; Pingitore A; Strata E; Di Bella G; Formisano F; Spirito P; Lombardi M
    J Cardiovasc Magn Reson; 2010 Apr; 12(1):21. PubMed ID: 20374627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late Gadolinium Enhancement for Prediction of Mutation-Positive Hypertrophic Cardiomyopathy on the Basis of Panel-Wide Sequencing.
    Teramoto R; Fujino N; Konno T; Nomura A; Nagata Y; Tsuda T; Tada H; Sakata K; Yamagishi M; Hayashi K; Kawashiri MA
    Circ J; 2018 Mar; 82(4):1139-1148. PubMed ID: 29398688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
    Langer C; Schaefer P; Lutz M; Eden M; Hohnhorst M; Harders H; Faber L; Jansen O; Both M; Frey N
    J Comput Assist Tomogr; 2015; 39(5):797-803. PubMed ID: 26125299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.